Abstract:This study introduces a novel approach to construct functional skeletal muscle organoid‐on‐a‐chip by leveraging mechanical boundary constraints, yielding highly organized muscle structures and contractile functionality. The pathological model reveals adaptive and decompensatory responses of muscles under different intermittent hypoxia and serves as a reliable platform for drug screening, highlighting its potential in disease modeling and regenerative therapies. Generating highly organized skeletal muscle tissues that mimics the cellular alignment, maturation, and contraction of native skeletal muscle remains a challenge in disease modeling and regenerative therapies. Existing methodologies are constrained by complexity in fabrication and difficulty in achieving aligned 3D myofibers. Here, a functional skeletal muscle organoid‐on‐a‐chip (SMO) is engineered by establishing mechanical boundary constraints at either end of the cell‐laden extracellular matrix hydrogel within polydimethylsiloxane microstructures to promote the formation of an anisotropic biophysical microenvironment in tissues. The linearly aligned tissue, featuring multinucleated myofibers with distinct cross‐striations, exhibited a positive force‐frequency relationship and stable calcium transients under electrical stimulation. SMOs applicability is demonstrated by systematically evaluating muscle response to varying degrees of intermittent hypoxia. Murine‐ or human‐derived SMOs revealed that, with increasing hypoxia severity, muscles transitioned from a compensatory phase‐characterized by enhanced contractile function, vacuolation and hypertrophic‐like changes in myofibers, fiber type switching, and metabolic shift, to a decompensatory stage, paralleling in vivo muscle responses and highlighting interspecies differences. Human‐derived SMOs are also utilized to assess self‐repair capabilities and pharmaceuticals protective effects on damaged muscle. Together, the platform, with its simplicity of operation and reliable phenotypic readouts, demonstrates significant potential for future disease modeling and regenerative therapies.

An Engineered Anisotropic Skeletal Muscle Organoid‐on‐a‐Chip for Deciphering Muscle Response under Intermittent Hypoxia (Adv. Funct. Mater. 39/2024)

An Engineered Anisotropic Skeletal Muscle Organoid‐on‐a‐Chip for Deciphering Muscle Response under Intermittent Hypoxia

Synergistic Modulation of a Tunable Microenvironment to Fabricate a Liver Fibrosis Chip for Drug Testing.

Compliant 3D frameworks instrumented with strain sensors for characterization of millimeter-scale engineered muscle tissues

Formation and Optogenetic Control of Engineered 3D Skeletal Muscle Bioactuators

Cardiac Meets Skeletal: What’s New in Microfluidic Models for Muscle Tissue Engineering

Latest developments in engineered skeletal muscle tissues for drug discovery and development

On-chip monitoring of skeletal myoblast transplantation for the treatment of hypoxia-induced myocardial injury.

Biosensors integrated 3D organoid/organ-on-a-chip system: A real-time biomechanical, biophysical, and biochemical monitoring and characterization

Biomimetic Approach to Cardiac Tissue Engineering: Oxygen Carriers and Channeled Scaffolds

Optimizing the structure and contractility of engineered skeletal muscle thin films.

Microfluidic intestinal organoid-on-a-chip uncovers therapeutic targets by recapitulating oxygen dynamics of intestinal IR injury

Empowering engineered muscle in biohybrid pump by extending connexin 43 duration with reduced graphene oxides

Musculoskeletal Organs‐on‐chips: An Emerging Platform for Studying the Nanotechnology‐Biology Interface

Studying the impact of geometrical and cellular cues on myogenesis with a skeletal muscle-on-chip

A Micromanipulation‐Actuated Large‐Scale Screening to Identify Optimized Microphysiological Model Parameters in Skeletal Muscle Regeneration

Multiscale Anisotropic Scaffold Integrating 3D Printing and Electrospinning Techniques as a Heart‐on‐a‐Chip Platform for Evaluating Drug‐Induced Cardiotoxicity (Adv. Healthcare Mater. 24/2023)

Heart-on-a-Chip Model with Integrated Extra- and Intracellular Bioelectronics for Monitoring Cardiac Electrophysiology under Acute Hypoxia

Micro‐Engineered Heart Tissues on‐Chip with Heterotypic Cell Composition Display Self‐Organization and Improved Cardiac Function

Organ chips with integrated multifunctional sensors enable continuous metabolic monitoring at controlled oxygen levels

Human Organ-on-a-Chip Microphysiological Systems to Model Musculoskeletal Pathologies and Accelerate Therapeutic Discovery